BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.
BTIG Downgrades Applied Genetic to Neutral
BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.
Related Posts
Datadog, Uber, S&P Global And More: CNBC’s ‘Final Trades’
Datadog clocked fiscal first-quarter revenue growth of 27% year-on-year to $611.3 million.
Rosenblatt Maintains Buy Rating for Seagate Tech Hldgs: Here’s What You Need To Know
Rosenblatt has decided to maintain its Buy rating of Seagate Tech Hldgs (NASDAQ:STX) and raise its price target…
Analyst Ratings for Voya Financial
Over the past 3 months, 7 analysts have published their opinion on Voya Financial (NYSE:VOYA) stock. These analysts…